Trinity biotech reaches profitability inflection point, marking major milestone in strategic turnaround

-trinity biotech projects it reached adjusted ebitda 1 -positive operations during q2 2025 and expects to be adjusted ebitda 1 positive going forward, reflecting continued strong execution on its comprehensive transformation plan.-
TRIB Ratings Summary
TRIB Quant Ranking